Yanhong Gu Selected Research

Yanhong Gu Research Topics

Disease

45	Neoplasms (Cancer) 03/2024 - 05/2006
22	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 07/2014
17	Colonic Neoplasms (Colon Cancer) 03/2024 - 04/2014
10	Inflammation (Inflammations) 01/2022 - 11/2013
9	Neoplasm Metastasis (Metastasis) 01/2019 - 02/2014
8	Colitis 01/2022 - 10/2012
6	Stomach Neoplasms (Stomach Cancer) 01/2022 - 05/2009
6	Carcinogenesis 01/2019 - 12/2011
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2015 - 03/2011
4	Liposarcoma 02/2015 - 03/2011
3	Bites and Stings (Sting) 01/2023 - 01/2021
3	Pneumonia (Pneumonitis) 01/2022 - 12/2019
3	Melanoma (Melanoma, Malignant) 01/2022 - 02/2014
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 11/2020
3	Carcinoma (Carcinomatosis) 01/2022 - 03/2017
3	Kidney Neoplasms (Kidney Cancer) 05/2021 - 02/2009
3	Diarrhea 01/2019 - 07/2014
3	Renal Cell Carcinoma (Grawitz Tumor) 05/2015 - 04/2010
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2014 - 05/2013
2	Infections 02/2024 - 06/2014
2	Mucositis 07/2023 - 01/2022
2	Hepatitis 01/2022 - 11/2021
2	Margins of Excision 01/2022 - 01/2018
2	Arthritis (Polyarthritis) 01/2022 - 11/2013
2	Lymphoma (Lymphomas) 12/2020 - 06/2014
2	Leukemia 12/2020 - 04/2014
2	Body Weight (Weight, Body) 12/2020 - 06/2014
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 11/2020 - 01/2018
2	Fibrosis (Cirrhosis) 12/2019 - 01/2016
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 06/2013
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017 - 01/2011
2	Lung Neoplasms (Lung Cancer) 03/2015 - 01/2013
2	Immune System Diseases (Immune Disorders) 05/2013 - 10/2012
1	Microsatellite Instability 04/2024

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 12/2019 - 05/2006
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2013
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2024 - 01/2016
6	andrographolideIBA 07/2023 - 06/2014
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2017
6	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 10/2012
5	Fluorouracil (Carac)FDA LinkGeneric 02/2024 - 05/2009
5	Tyrosine Kinase InhibitorsIBA 01/2022 - 06/2013
5	InflammasomesIBA 12/2019 - 05/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
4	CateninsIBA 05/2021 - 05/2015
4	apatinibIBA 11/2020 - 01/2019
4	Messenger RNA (mRNA)IBA 11/2020 - 02/2014
4	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 05/2009
3	Phosphotransferases (Kinase)IBA 03/2024 - 02/2014
3	pembrolizumabIBA 01/2022 - 06/2019
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 12/2015
3	Granzymes (Granzyme)IBA 10/2021 - 01/2017
3	Interleukin-17 (Interleukin 17)IBA 02/2020 - 11/2013
3	Dextran SulfateIBA 01/2017 - 05/2013
3	Sulfonic AcidsIBA 01/2017 - 10/2012
3	icotinibIBA 12/2014 - 06/2013
3	ErbB Receptors (EGF Receptor)IBA 12/2014 - 03/2011
2	regorafenibIBA 03/2024 - 11/2021
2	SHP099IBA 03/2024 - 03/2019
2	Circular RNAIBA 02/2024 - 01/2018
2	sintilimabIBA 01/2023 - 01/2022
2	Therapeutic UsesIBA 01/2023 - 01/2020
2	Circulating Tumor DNAIBA 01/2023 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022 - 01/2021
2	PhosphopeptidesIBA 01/2022 - 11/2020
2	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2020
2	DiterpenesIBA 01/2022 - 12/2016
2	PhosphoproteinsIBA 01/2022 - 01/2021
2	andrographolide sulfonateIBA 10/2021 - 06/2014
2	Long Noncoding RNAIBA 07/2021 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2013
2	Pemetrexed (MTA)FDA Link 11/2020 - 08/2015
2	Protein Tyrosine PhosphatasesIBA 01/2020 - 04/2014
2	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 03/2019 - 04/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2018
2	Interleukin-18 (Interleukin 18)IBA 12/2017 - 12/2015
2	Cadherins (E-Cadherin)IBA 03/2017 - 05/2015
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017 - 10/2013
2	AzoxymethaneIBA 01/2017 - 06/2014
2	Sunitinib (Sutent)FDA Link 01/2016 - 04/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 05/2009
2	Protein Isoforms (Isoforms)IBA 06/2015 - 05/2015
2	Interleukin-15 Receptors (Interleukin 15 Receptor)IBA 05/2015 - 02/2009
2	Interleukin-15 (Interleukin 15)IBA 05/2015 - 02/2009
2	CurcuminIBA 10/2014 - 03/2011
2	Axitinib (AG 013736)IBA 07/2014 - 02/2014
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2014 - 02/2014
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2014 - 01/2011
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2014 - 03/2011
2	Adenosine Triphosphatases (ATPase)IBA 03/2014 - 03/2011

Therapy/Procedure

30	Therapeutics 04/2024 - 04/2010
14	Drug Therapy (Chemotherapy) 02/2024 - 03/2011
11	Immunotherapy 07/2023 - 02/2009
3	Radiotherapy 01/2024 - 12/2011
3	Intraperitoneal Injections 12/2020 - 06/2014
2	Neoadjuvant Therapy 01/2023 - 08/2020
2	Adjuvant Chemotherapy 01/2022 - 01/2016
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2021 - 01/2013
2	Renal Dialysis (Hemodialysis) 04/2021 - 11/2019